Amphotericin

This page contains recent news articles, when available, and an overview of Amphotericin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

BioDelivery Sciences Initiates Bioral ® Amphotericin B Clinical ...  -  Jul 28, 2008
In the Phase I trial, the Bioral ® technology will be evaluated as a potential means of orally delivering the antifungal agent Amphotericin B, an important Business Wire (press release),

Prominent Physician Achieves Success Using Topical Sinus ...  -  Aug 1, 2008
For fungal infections, he use antifungals (such as Amphotericin B or Itraconazole). For inflammation, he adds an anti-inflammatory (such as Mometasone or PR-USA.net (press release),

BioDelivery Initiates Phase I Study of Bioral Antifungal Drug  -  Jul 29, 2008
In the Phase I trial, the Bioral technology will be evaluated as a potential means of orally delivering the antifungal agent Amphotericin B, an important RedOrbit,

Drug delivery news in brief  -  Jul 30, 2008
The drug in the current trial is Amphotericin B, a treatment for serious fungal infections that is currently delivered intravenously. In-PharmaTechnologist.com,

Candida tropicalis spondylodiskitis in a patient with carcinoma of ...  -  Jul 29, 2008
Biopsy done via the posterior approach showed Candida tropicalis sensitive to fluconazole and resistant to Amphotericin B . Patient was treated with 7thSpace Interactive (press release),

Raleigh-based BioDelivery Sciences starts Phase I trial  -  Jul 28, 2008
Dr. Raphael Mannino, executive VP and Chief Scientific Officer at BDSI said, “The ability to orally administer Amphotericin B using the Bioral technology TechJournal South,

Primary Amebic Meningoencephalitis —Arizona, Florida, and Texas, 2007  -  Jul 8, 2008
Amphotericin B, rifampin, azithromycin, and fluconazole were administered; however, the boy died September 4. The patient's exposure history included Journal of American Medical Association (subscription),

Zoek in het archief  -  Jul 17, 2008
AmBisome For the second quarter of 2008, sales of AmBisome(R) (amphotericin B) liposome for injection for severe fungal infections were $69.8 million, Netherlands Corporate News (persbericht),

Condomizing Jesse Helms' House  -  Jul 17, 2008
Or if I'm taking amphotericin B, it could cause me to shake like crazy. Maybe wiring myself to a bomb would make more sense. But then I wouldn't be around Yahoo! News

iCo Therapeutics Appoints Mr. Noel Hall and Dr. Christian Fibiger ...  -  Jul 8, 2008
...history to be developed for severe ocular allergies, and iCo-009, an oral reformulation of Amphotericin B for sight and life - threatening diseases. Canada NewsWire (press release),

*vwd/BUSINESS WIRE: Gilead Sciences gibt die Finanzergebnisse des ...  -  Jul 21, 2008
AmBisome Die Produktverkäufe von AmBisome^ ®-(Amphotericin B)-Liposom zur Injektion für schwerwiegende Pilzinfektionen erreichten im zweiten Quartal 2008 ddp-direkt.de,

Cialis Is The Drug For Loving  -  Jul 30, 2008
Just after Ukmedix News reported that the drug company Eli Lilly has been stealing market share from the world famous erectile dysfunction drug Viagra with UKMedix Health News,

Martin Burke: The smart synthesizer  -  02 Jul 2008
Since 2005, Burke has headed his own lab at the University of Illinois where he's been investigating a small molecule called amphotericin B, Scientist,

Scientist's novel approach to Leishmaniasis treatment  -  Jul 1, 2008
Leishmaniasis current therapy is mainly based on the systemic administration of toxic pentavalent antimonials or amphotericin B, drugs with several side Scientist Live,

High-dose amphotericin B speeds clearance of cryptococcus from the ...  -  Jun 27, 2008
A combination of high-dose amphotericin B and flucytosine leads to faster declines in the presence of the fungus Cryptococcus in the brains of HIV-positive Aidsmap,

Coccidioides immitis Osteomyelitis of the Radius Presenting as ...  -  Jun 23, 2008
Infectious disease consultation was obtained and the patient was placed on amphotericin B. The patient required repeat irrigation and debridement 1 month Ortho SuperSite,

Gardeners: Be Cautious Of These Fungal Spores  -  Jun 14, 2008
Treatment with intravenous liposomal amphotericin B was started. The man was subsequently transferred to another unit for extracorporeal membrane Medical News Today,

iCo Therapeutics Closes $1140450 Financing  -  Jun 9, 2008
...history to be developed for severe ocular allergies, and iCo-009, an oral reformulation of Amphotericin B for sight and life-threatening diseases. Stockhouse,

Man dies after inhaling deadly garden fungus  -  Jun 12, 2008
Once the cause had been identified, the man was given another drug, liposomal amphotericin B, and received a treatment called extra-corporeal membrane Lanka Business Online,

iCo Therapeutics Reports New iCo-009 (Oral Amphotericin B ...  -  Jun 26, 2008
..."This data serves as further validation of iCo-009's ability to safely kill fungal infections without the need to intravenously infuse Amphotericin B," PharmaLive.com (press release),

University of British Columbia is Latest to Adopt Global Access ...  -  Jun 4, 2008
The agreement will allow Vancouver-based iCo Therapeutics to commercialize an oral formulation of the drug amphotericin B, which was developed at UBC. Biotech Transfer Week,

Acute kidney failure more common in people newly diagnosed with HIV  -  Jun 25, 2008
Drugs used to treat these infections that are known to be nephrotoxic include amphotericin B, aminoglycosides, sulfadiazine, high-dose cotrimoxazole Aidsmap,

On the Pulse - 20th June  -  Jun 20, 2008
Despite treatment with intravenous liposomal amphotericin B and venovenous extra-corporeal membrane oxygenation, he rapidly died of overwhelming sepsis. OnMedica,

Gardening: The lethal fungi that may be in your garden  -  Jun 19, 2008
...he may have been saved had they given him voriconazole instead of liposomal amphotericin B, which their hospital trust was recommending at the time. What Doctors Don't Tell You,

Warning to Gardeners about Deadly Fungus  -  Jun 18, 2008
The man’s fungal infection was treated with intravenous liposomal amphotericin and extra-corporeal membrane oxygenation but his blood pressure remained too Ivanhoe,

iCo Therapeutics Closes $1140450 Financing  -  Jun 9, 2008
...history to be developed for severe ocular allergies, and iCo-009, an oral reformulation of Amphotericin B for sight and life-threatening diseases. Canada NewsWire (press release),

CD4 count and PCR key to predicting relapses of leishmaniasis  -  Jun 5, 2008
The small cohort comprised 27 patients with AIDS who had a diagnosis of leishmaniasis, were treated with amphotericin B for the infection, and then put on Aidsmap,

Critical Therapeutics Completes Phase II Clinical Trial for ...  -  Jun 3, 2008
LEXINGTON, Mass.--(BUSINESS WIRE)--Jun 2, 2008 - Critical Therapeutics, Inc. (Nasdaq: CRTX) today announced top-line results from its Phase II clinical PharmaLive.com (press release),

Polytherics Complex technology to make drug solubility simple  -  02 Jun 2008
The improved solubility and circulatory half-life of the new amphotericin formulation is designed to extend its period of therapeutic efficacy and allow the In-PharmaTechnologist.com,

Aerosolized Liposomal Amphotericin B Prevents Pulmonary Aspergillosis  -  May 27, 2008
By Megan Rauscher NEW YORK MAY 26, 2008 (Reuters Health) - Prophylactic inhalation of aerosolized liposomal amphotericin B is an effective way to prevent Cancerpage.com,

iCo Therapeutics Acquires Worldwide Rights to iCo-009 (Oral ...  -  May 7, 2008
..."iCo views the enormous market and compassionate use potential of a novel, oral Amphotericin drug as a win-win scenario for shareholders and our global Canada NewsWire (press release),

Cationic nanoparticles for delivery of amphotericin B: preparation ...  -  May 7, 2008
In this work, cationic nanoparticles built from drug, cationic lipid and polyelectrolytes are shown to be excellent and active carriers of amphotericin B 7thSpace Interactive (press release),

Novel Approach To Drug Insolubility Strengthens PolyTherics Patent ...  -  May 28, 2008
One successful application of the technology has been for the fungicide Amphotericin B. PolyTherics has teamed up with the Drugs for Neglected Diseases Medical News Today (press release),

Survival after cryptococcal meningitis not improving despite ART ...  -  May 20, 2008
CM treatment in Africa is based on amphotericin B and fluconazole while in North America it is based on a combination of amphotericin B, flucytosine, Aidsmap,

iCo Therapeutics First Quarter Financial Results  -  May 30, 2008
...history to be developed for severe ocular allergies, and iCo-009, an oral reformulation of Amphotericin B for sight and life - threatening diseases. Canada NewsWire (press release),

Wyeth Receives Approvable Letter from FDA for TYGACIL for the ...  -  May 29, 2008
...simultaneously through the same Y-site as TYGACIL: amphotericin B and diazepam For a copy of TYGACIL Prescribing Information, please visit www. PR Newswire (press release),

South Asia News in brief: 16–29 May 2008  -  May 29, 2008
...a widespread tropical disease spread by sandflies, can be improved by using nanoparticles of the common antileishmanial drug amphotericin. SciDev.net,

After a Hectic Week, a Partylike Evening at Phillips de Pury ...  -  May 15, 2008
Among the most popular was “Amphotericin B�? (the title comes from a chemical compound), a 1993 example of the artist’s “dot paintings. New York Times,

Micronized Itraconazole: Another Topical Choice for Fungal Sinus ...  -  May 26, 2008
Science program has observed positive results utilizing Itraconazole as an alternative to Amphotericin B for treating Allergic Fungal Sinus Infections. PR Web (press release),

Cancer concerns over carbon nanotubes  -  May 20, 2008
Srivastava’s group at BHU makes carbon tubes and functionalizes them for use in research for delivering a cancer drug, amphotericin-B. Livemint,

Explosive Auction Week Culminates at Phillips  -  May 16, 2008
...$1.2–1.8 million); and Damien Hirst's Amphotericin B, which earned $3177000 (est. $3–4 million). As at this week's Sotheby’s and Christie’s sales, ARTINFO,

UBC Global Access Agreement with iCo Therapeutics Offers Oral Drug ...  -  May 13, 2008
The agreement will allow Vancouver-based iCo Therapeutics to commercialize an oral formulation of the drug Amphotericin B that was developed by Drs. Kishor University of British Columbia,

iCo Therapeutics to Present at BioFinance 2008  -  May 5, 2008
...iCo Therapeutics has an exclusive option to license iCo-009, a oral reformulation of Amphotericin B for sight and life-threatening diseases. Canada NewsWire (press release),

The terrible price of forgetting  -  Apr 1, 2008
The WHO gives the highest therapeutic index of existing drugs for kala azar to liposomal amphotericin B. Not only is it the safest and most effective drug Indian Express,

Other News To Note  -  Apr 21, 2008
...oral formulation of the generic drug Amphotericin B, a clinical path and its proposed 505(b)(2) strategy for iCo-009 will be discussed in the meeting. TMCnet

Accentia’s Chronic Sinusitis Product Fails Clinical Trial  -  Apr 1, 2008
However, Accentia maintains SinuNase (topical amphotericin B 0.01 percent suspension) is viable. It plans to conduct a full data analysis of the primary and FDA news (subscription),

Accentia Shares Nosedive on Negative SinuNase Data  -  Mar 25, 2008
Accentia Biopharmaceuticals Inc. shares plummeted 67.6 percent Tuesday, the first trading day after it said its nasal syringe SinuNase (amphotericin B) for Therapeutics Daily (subscription) (press release),

Mixed News for Sinusitis Drug  -  Mar 25, 2008
...show the required level of statistical significance when comparing the SinuNase (topical amphotericin B 0.01 percent suspension) arm with the control. FDA news (subscription),

Candida Causes, Symptoms, Diagnosis and Treatment  -  Apr 19, 2008
...nystatin, tioconazole (Vagistat Vaginal), or oral administration of drugs such as fluconazole (Diflucan) and amphotericin B. Many women prefer a single, Los Angeles Chronicle,

Skin mucormycosis presenting as an erythema-nodosum-like rash in a ...  -  Apr 19, 2008
The patient was treated successfully with amphotericin B and surgical resection. To our knowledge, this is the first description of primary cutaneous 7thSpace Interactive (press release),

Benefit is a dose of life support for family of boys with rare ...  -  Apr 18, 2008
She recalled when Robert had to take amphotericin, an antifungal medication that he was hooked up to for eight hours at a time, making him sick and weak, Beaumont Enterprise,

Gilead Sciences Announces First Quarter 2008 Financial Results  -  Apr 16, 2008
Sales of AmBisome(R) (amphotericin B) liposome for injection for the first quarter of 2008 were $71.0 million, an increase of 15 percent from $61.5 million Centre Daily Times,

AEterna Zentaris and Paladin Labs Complete Sale and Purchase of ...  -  Apr 1, 2008
Other currently available treatments are liposomal amphotericin (Ambisome®) and Paromomycin. Leishmaniasis is an infectious disease transmitted by the bite CNNMoney.com

Treatment of Acute and Chronical Bacterial Prostatitis Caused by ...  -  Apr 8, 2008
The novel lipid formulation of amphotericin and the echinocandins (caspofungin, micafungin) have demonstrated unique antifungal activity against Candida ScienceBlog.com,

Antimicrobial Pharmacodynamics in Theory and Clinical Practice  -  Mar 25, 2008
For example, amphotericin is mentioned as the drug of choice for the treatment of Aspergillus sp, whereas newer guidelines recommend voriconazole. Journal of American Medical Association (subscription),

Unusual 11 Mid-Day Movers 3/25: TMA, SEED, GDP, SOL Higher; ABPI ...  -  Mar 25, 2008
SinuNase (topical amphotericin B 0.01% suspension) achieved, as anticipated, superior resolution of the cardinal symptoms of chronic sinusitis (CS), StreetInsider.com (subscription),

Natural Approaches for the Prevention of Oral Cancer and ...  -  Apr 3, 2008
Clotrimazole, Amphotericin B and Nystatin) which most of these patients cannot afford full dose. This has resulted in the development of Candida strains Natural News.com,

New scientific data on ceftobiprole and isavuconazole will be ...  -  Apr 18, 2008
Correlation of in vitro MIC and MFC against isavuconazole, voriconazole and amphotericin B of Aspergillus with in vivo outcome in mice with disseminated Genetic Engineering News (press release),

MG Strategies: Accentia Pharmaceuticals Inc. Review in Progress  -  Mar 25, 2008
...the Company's intranasal, low-dose antifungal lavage product, SinuNase (topical amphotericin B 0.01% suspension) for the treatment of chronic sinusitis. Trading Markets (press release),

iCo Therapeutics Provides iCo-008 Phase II Clinical Update  -  10 Mar 2008
...iCo Therapeutics has an exclusive option to license iCo-009, an oral reformulation of Amphotericin B for sight and life-threatening diseases. Canada NewsWire (press release),

AEZ: Sale of Miltefosine to Paladin Labs for C$9.125M  -  Mar 3, 2008
Other current available treatments are liposomal amphotericin (Ambisome(R)) and Paromomycin. KNOBIAS DISCLAIMER: All statements made in this article were Trading Markets (press release),

AEterna Zentaris and Paladin Labs Announce Sale and Purchase of ...  -  Mar 3, 2008
Other current available treatments are liposomal amphotericin (Ambisome®) and Paromomycin. Leishmaniasis is an infectious disease transmitted by the bite of CNNMoney.com

iCo Therapeutics Announces Chief Medical Officer Invited to ...  -  Feb 27, 2008
...iCo Therapeutics also has an exclusive option to license iCo-009, a oral reformulation of Amphotericin B for sight and life - threatening diseases. Canada NewsWire (press release),

Analyse the Molecules That Changed the World  -  Feb 22, 2008
Longifolene Prostaglandins & Leukotrienes Vitamin B12 Erythronolide B & Erythromycin A Monensin Avermectin Amphotericin B Ginkgolide B Cyclosporin, StreetInsider.com (subscription),

Enzon Reports Solid 2007 Results  -  Feb 14, 2008
Sales in the US and Canada of Abelcet, a lipid complex formulation of amphotericin B used primarily in the hospital to treat immuno-compromised patients Centre Daily Times,

iCo Therapeutics Provides iCo-009 (Oral Amphotericin B) Update  -  Jan 21, 2008
21 /CNW/ - iCo Therapeutics Inc. (TSX-V: ICO) is pleased to provide an update on the Company's iCo-009 program, an oral reformulation of Amphotericin B Canada NewsWire (press release),

Gilead Sciences Announces Fourth Quarter and Full Year 2007 ...  -  Jan 23, 2008
AmBisome for Severe Fungal Infections Sales of AmBisome® (amphotericin B) liposome for injection for the fourth quarter of 2007 were $67.8 million, WELT ONLINE,

LiquidStockReport.com: QEDs Omni Manager Replaces RTCCs Current ...  -  Jan 11, 2008
The company's product pipeline also includes Bioral formulation, which is an encochleated version of Amphotericin B; and a second formulation for intranasal Trading Markets (press release),

Gilead Sciences Announces Fourth Quarter and Full Year 2007 ...  -  Jan 24, 2008
Sales of AmBisome® (amphotericin B) liposome for injection for the fourth quarter of 2007 were $67.8 million, an increase of 16 percent from $58.3 million Lifescience-online,

BUYINS.NET: (ALO) SqueezeTrigger Price is $21.324. There is ...  -  Feb 4, 2008
The Company's API business also manufactures other antibiotic active substances, such as tobramycin, colistin and methsulfate and colistin and amphotericin Trading Markets (press release),

:

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.